Circulation-Cardiovascular Interventions

Papers
(The TQCC of Circulation-Cardiovascular Interventions is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Novel Antithrombotic Strategies After Surgical Bioprosthetic Valve Replacement166
Adjunctive Imaging and Physiology During PCI Among Black and White Medicare Beneficiaries: Disparities in Utilization Patterns and Outcomes100
The Beaten Path: Use of the Radial Artery as a Bypass Graft After Instrumentation80
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial76
Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Older Adults Receiving Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock73
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI67
Is Stable CAD the Same in All Circumstances? The Curious Case of PCI Before TAVR64
Contemporary State-of-the-Art PCI of Left Main Coronary Artery Disease61
Fatal Steam Pop Complicating Investigational SESAME Transcatheter Myotomy Using Off-the-Shelf Equipment54
ACURATE neo2 Versus SAPIEN 3 Ultra Transcatheter Heart Valve in Severe Aortic Valve Calcification: A Propensity-Matched Analysis54
Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation54
Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE54
Prospective Multicenter IDE Study of the Next-Generation Precision Aspiration Thrombectomy System for Intermediate-Risk Pulmonary Embolism: The SYMPHONY-PE Trial53
Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry46
Percutaneous Balloon–Expandable Stent Implantation to Treat Transverse Aortic Arch Obstruction: Medium- to Long-Term Outcomes of a Retrospective Multicenter Study45
Perfect Wedding Between Patient With STEMI and Angiography-Derived Indexes of Coronary Physiology44
Supplementing Randomized Trial Data to Answer a Real-World Question: Discharge to Home Status as a Heuristic for Stroke Severity After TAVR42
Letter by Güner et al Regarding Article, “Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection”41
Temporal Trends in In-Hospital Outcomes Following Unprotected Left-Main Percutaneous Coronary Intervention: An Analysis of 14 522 Cases From British Cardiovascular Intervention Society Database 2009 t38
Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction37
Preventing Complications of Mechanical Circulatory Support Devices: The Clue for Improved Outcomes?37
Angina After Percutaneous Coronary Intervention?37
Giant Aberrant Vascular Structure Extending From the Left Ventricular Apex to the Umbilicus in a Newborn With Cantrell Pentalogy: Management and Transcatheter Closure36
Prognostic Implications of Bleeding and Ischemic Complications in Acute Myocardial Infarction-Related Cardiogenic Shock Managed With Microaxial Flow Pump36
Timing of Intervention and Long-Term Outcomes in Mild Congenital Heart Disease: A 35-Year Study From the Pediatric Cardiac Care Consortium35
Response by Yamamoto et al to Letter Regarding Article, “Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention”35
Efficacy of the Glucagon-Like Peptide-1 Agonist Exenatide in Patients Undergoing CABG or Aortic Valve Replacement: A Randomized Double-Blind Clinical Trial35
Optimal Hemostatic Band Duration After Transradial Angiography or Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials34
Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials34
Letter by Skalidis et al Regarding Article, “Angiography-Derived Fractional Flow Reserve During Percutaneous Coronary Intervention”34
Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions33
Intravascular Imaging for Optimal Left Main Percutaneous Coronary Intervention: A Requirement Rather Than an Option33
Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis32
Letter by Garmendia and Garcia-Garcia Regarding Article, “Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention”31
Tricuspid Clip at 2 Years: Clocking the Development of a Rapidly Expanding Space30
Workflow for Percutaneous Coronary Intervention With Optical Coherence Tomography-Guidance: MAXing the MLD?29
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial27
Will a Conservative Case Selection Strategy Improve Hospital-Level TAVR Performance Metrics?27
Simple Maneuver to Improve TriClip Eligibility in Patients With Cardiac Implantable Electronic Device Leads26
Microvascular and Macrovascular Disease: The S’mores of Peripheral Artery Disease25
Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: Lessons Learned After the Learning Curve Period25
Contemporary Anatomic Criteria and Clinical Outcomes With Transcatheter Mitral Repair25
Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study25
A Tale of Two Polymers: Bioprosthetic Valve Remodeling Versus Bioprosthetic Valve Fracture of Mosaic Surgical Valves to Facilitate VIV TAVR25
Microvascular Function and Ambulatory Capacity in Peripheral Artery Disease25
Composite Pulmonary Embolism Shock Score and Risk of Adverse Outcomes in Patients With Pulmonary Embolism25
Comparative Outcomes of Transcatheter Edge-to-Edge Repair and Tricuspid Valve Surgery for Isolated Tricuspid Valve Regurgitation24
Why Age Matters: Revascularization Strategy and Outcomes in Young and Elderly With CLTI24
Does CRT Reduce Health Care–Related Costs in Patients With ANOCA?24
Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis24
Fetal Atrial Septal Intervention for HLHS With Restrictive Septum: Promising Progress, Persistent Questions24
Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance23
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk Patients23
Expecting the Unexpected: Insights and Uncertainties From the ALTERRA Trial 3-Year Results23
Mechanisms Matter: Combining Invasive Metrics to Better Define Microvascular Dysfunction23
Reperfusion Delays and Outcomes Among Patients With ST-Segment–Elevation Myocardial Infarction With and Without Cardiogenic Shock22
Impact of Left Atrial Pressure on Outcomes After Mitral Transcatheter Edge-to-Edge Repair22
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses22
Outcomes of Transcatheter Tricuspid Edge-to-Edge Repair in Patients With Right Ventricular Dysfunction22
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk22
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients22
Editors and Editorial Board22
Clinical Value of Single-Projection Angiography–Derived FFR in Noninfarct-Related Artery22
Hybrid Versus Percutaneous Left Atrial Decompression in Infants With Hypoplastic Left Heart Variants and an Intact or Highly Restrictive Atrial Septum: A Multicenter PICES Study21
Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry21
Graft Patency and Clinical Outcomes in Patients With Radial Artery Grafts Previously Instrumented for Cardiac Catheterization21
Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis21
Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis21
Enhancing Coronary Revascularization Decisions: The Promising Role of Large Language Models as a Decision-Support Tool for Multidisciplinary Heart Team20
Enhancing Guidewire Efficacy for Transradial Access: The EAGER Randomized Controlled Trial20
Extended Rhythm Monitoring to Assess for Ventricular Arrhythmias After Transcatheter Pulmonary Valve Replacement With the Harmony Valve20
Temporal Trends and Predictors of Access Site Crossover During PCI in Contemporary Practice: A Report From the NCDR CathPCI Registry20
Large Animal Translational Validation of 3 Mitral Valve Repair Operations for Mitral Regurgitation Using a Mitral Valve Prolapse Model: A Comprehensive In Vivo Biomechanical Engineering Analysis20
Still a Long Way to the Precision Medicine of Antiplatelet Strategy After Percutaneous Coronary Intervention19
Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation19
What Predicts the Success of Alcohol Septal Ablation?: The Myocardium Counts, After All19
Response to Letter by Piriou et al Regarding Article, “Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation”19
Zipping Versus Clover Repair in Transcatheter Edge-to-Edge Tricuspid Repair: Insights From the TRI-SPA Registry19
More Is Not Always Better: Reassessing Acetylcholine Provocation in the Diagnosis of Coronary Vasospasm19
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI19
DanGers of Delays in Cardiogenic Shock: Benefit Persists But Attenuates19
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial18
Associations of Sarcopenia and Body Composition Measures With Mortality After Transcatheter Aortic Valve Replacement18
Technical Advances and Outcomes of Fetal Atrial Septal Intervention for Restrictive or Intact Atrial Septum18
Cardiac Structural Complications in TAVR: A Persistent Challenge in the Modern Era18
Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA18
Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry18
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial18
Invasive Coronary Function Testing in Patients With Prior PCI Who Have Persistent ANOCA18
Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Outcome in Patients With ST-Segment–Elevation Myocardial Infarction17
Sirolimus-Coated Balloons for In-Stent Restenosis: The Evolution of PCI17
Direct Oral Anticoagulants Versus Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Trials17
Letter by Skalidis et al Regarding Article, “Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Stu17
Invasive or CT Angiography: Alternative or Complementary Imaging Tools After CABG?17
Transcatheter Mitral Valve-in-Valve Replacement as a First-Line Treatment for Bioprosthetic Valve Failure17
Comparison of Transcatheter Edge-to-Edge Mitral Valve Repair for Primary Mitral Regurgitation Outcomes to Hospital Volumes of Surgical Mitral Valve Repair17
Shorter Time to Transcatheter Aortic Valve Implantation Is Associated With Improved Outcomes in Acute Decompensated Aortic Stenosis17
Metrics to Assess Quality Following Percutaneous Coronary Intervention Complications: Is “Failure to Rescue” an Answer?17
Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement16
Comprehensive Diagnosis of Myocardial Ischemia of Obstructive and Nonobstructive Origin With a Wire-Free Diagnostic Strategy16
Temporal Changes in Procedural Success and Clinical Outcomes of MTEER by Mechanism of MR: Analysis of the STS/TVT Registry16
Implementation of a Multidimensional Strategy to Reduce Post-PCI Bleeding Risk16
Timing of ECLS Initiation and Outcomes in Acute Myocardial Infarction-Related Cardiogenic Shock: A Predefined Subanalysis of the ECLS-SHOCK Trial15
Randomized Study Comparing Angiography Guidance With Physiology Guidance After PCI: The EASY-PREDICT Study15
Transcatheter Mitral and Aortic Paravalvular Leak Closure: Innovations, Challenges, and Future Directions15
Stent-Edge Hinge Movement in a Calcified Lesion Is Associated With Increased Prevalence of a Calcified Nodule at Follow-Up14
Expanding Transcatheter Tricuspid Valve Replacement Applicability—Beyond Device Iterations14
Pulmonary Artery Systolic Pressure Trajectories After Transcatheter Edge-to-Edge Repair in Atrial and Ventricular Secondary Mitral Regurgitation14
Novel Real-Time Fluoroscopic Assessment Method of THV Expansion Following Balloon-Expandable TAVR14
Natural History of Coronary Atherosclerosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: The Role of Quantitative Flow Ratio14
Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis14
Impact of Intensity of Vascular Care Preceding Major Amputation Among Patients With Chronic Limb-Threatening Ischemia13
Feasibility of Redo-Transcatheter Aortic Valve Replacement in Sapien Valves Based on In Vivo Computed Tomography Assessment13
Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 Registries13
Transcatheter Valve Replacement in Adults With Congenital Heart Disease—The Mayo Clinic Experience13
Efficacy and User Experience of a Novel X-Ray Shield on Operator Radiation Exposure During Cardiac Catheterization: A Randomized Controlled Trial13
Coronary Artery Obstruction After Transcatheter Aortic Valve Implantation: Past, Present, and Future13
Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves12
Time Course of Microvascular Stunning in ST-Segment–Elevation Myocardial Infarction12
Temporal Trends in Isolated and Concomitant Aortic Valve Replacement for Aortic Stenosis in Patients Aged <65 Years12
PCI for Surgically Ineligible Patients: Another Piece of the Jigsaw12
Dynamic Nature of the Hyperemic Continuum12
Association Between Artificial Intelligence-Detected Features on the ECG and Presence of Microvascular Obstruction12
Response by Costa et al to Letter Regarding Article, “Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation”12
Challenges and Evolving Strategies in the Treatment of In-Stent Restenosis With Drug-Coated Balloons12
Virtual FFR From Optical Coherence Tomography: A 1-Stop Shop for PCI Guidance?12
Response to Letter Regarding Article, “Interpreting AI noise Driven Radiation Reduction in Coronary Angiography: The Role of Technical and Clinical Determinants”11
TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review11
Hemodynamic Super-Responders in Pulmonary Embolism: Optimism and Uncertainty11
One-Year Outcomes of Screen Failures for Transcatheter Tricuspid Valve Repair: Insights From the TriSelect Study11
Statewide Initiative to Reduce Patient Radiation Doses During Percutaneous Coronary Intervention11
FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs11
Can TAVR Be Safely Performed in Patients With Bicuspid Aortic Valve Morphology?11
CCTA-Guided Invasive Coronary Angiography in Patients With CABG: A Multicenter, Randomized Study11
Single Bolus r-SAK Before Primary PCI for ST-Segment–Elevation Myocardial Infarction11
Prospective Validation of the MIRACLE 2 Score for Early Neurological Stratification After Out-of-Hospital Cardiac-Arrest: The GLOBAL-MIRACLE Registry10
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort10
Coronary Sinus Reduction: Can Device-Based Therapy Improve Coronary Microvascular Function?10
CT Simulation for Redo-TAVR: Can We Predict Future Coronary Access?10
Correction to: Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention10
Predictive Value of Platelet FcγRIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial Infarction10
Navigating the Course of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Review of Guided Approaches10
Seeing More With Less: AI to Reduce Radiation Exposure in the Cath Lab10
Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions10
Response by Brilakis et al to Letter Regarding Article, “Chronic Total Occlusion Percutaneous Coronary Intervention: Present and Future”10
Ultra-Low Contrast IVUS-Guided PCI in Patients With Severe Chronic Kidney Disease: An Observational Prospective Study10
Prognostic Impact of Left Atrial Appendage Patency After Device Closure10
Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention10
Contrast-Derived Index of Microcirculatory Resistance: A Novel Index for Measuring Coronary Microvascular Resistance10
Editors and Editorial Board10
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Nationwide Prospective Multicenter Registry in Japan (J-BPA)10
0.18911194801331